MERIT MEDICAL SYSTEMS INC (MMSI) Stock Analyst Ratings
NASDAQ:MMSI - Nasdaq - US5898891040 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 85% to MMSI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 109.24. This target is 14.86% above the current price.
MMSI was analyzed by 17 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about MMSI.
In the previous month the buy percentage consensus was at a similar level.
MMSI was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-21 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-05-21 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-05-20 | Needham | Reiterate | Buy -> Buy |
| 2025-05-15 | Needham | Maintains | Buy -> Buy |
| 2025-04-25 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-04-25 | Needham | Maintains | Buy -> Buy |
| 2025-04-25 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-04-25 | Baird | Maintains | Outperform -> Outperform |
| 2025-04-25 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-04-23 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-04-11 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-04-09 | Needham | Reiterate | Buy -> Buy |
| 2025-03-28 | JP Morgan | Initiate | Overweight |
| 2025-02-26 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-02-26 | Needham | Maintains | Buy -> Buy |
| 2025-02-26 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-02-26 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-01-29 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-01-29 | Needham | Maintains | Buy -> Buy |
| 2025-01-29 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-01-29 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2025-01-21 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-01-14 | Needham | Reiterate | Buy -> Buy |
| 2024-12-31 | Raymond James | Maintains | Outperform -> Outperform |
| 2024-12-23 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-12-11 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2024-12-09 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-10-31 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-10-31 | Needham | Reiterate | Buy -> Buy |
| 2024-10-31 | Baird | Maintains | Outperform -> Outperform |